IHT Wealth Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

IHT Wealth Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,000	Closed	-$2K	–	1620
2018 Q1	$2K	Buy	+5,000	New	+$7.47K	﹤0.01%	1554

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

IHT Wealth Management's ANTH Position: Q2 2018 in Review

IHT Wealth Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 5,000 shares — an estimated $2K sold.

IHT Wealth Management first reported a position in ANTH in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

IHT Wealth Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 5,000 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $2K.
IHT Wealth Management first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
IHT Wealth Management's Anthera Pharmaceuticals, Inc. position peaked at $2K in Q1 2018.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.